Article
Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Apr 2013
Russell Prudence A, Barnett Stephen A, Walkiewicz Marzena, Wainer Zoe, Conron Matthew, Wright Gavin M, Gooi Julian, Knight Simon, Wynne Rochelle, Liew Danny, John Thomas
Abstract excerpt
INTRODUCTION: We investigated the relationship between predominant subtype, according to the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification; mutation status; and patient outcome in stage III (N2) lung adenocarcinoma. METHODS: We identified 69 patients with stage III (N2) lung...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.